ISO 21474-2:2022
体外诊断医疗器械.核酸的多重分子试验.第2部分:验证和验证

In vitro diagnostic medical devices — Multiplex molecular testing for nucleic acids — Part 2: Validation and verification

ISO 21474-2:2022 发布历史

This document gives the general requirements for validation and verification of multiplex molecular tests which simultaneously identify two or more nucleic acid target sequences of interest. This document is applicable to all multiplex methods used for examination using IVD medical devices and laboratory developed tests (LDTs). It provides information for both qualitative and quantitative detection of nucleic acid target sequences. This document is intended as guidance for multiplex examinations that either detect and/or quantify human nucleic acid target sequences or microbial pathogen nucleic acid target sequences from human clinical specimens. This document is applicable to any molecular in vitro diagnostic (IVD) examination performed by medical laboratories. It is also intended to be used by laboratory customers, IVD developers and manufacturers, biobanks, institutions, and commercial organizations performing biomedical research and regulatory authorities. This document is not applicable to metagenomics. NOTE An examination procedure developed for a laboratory’s own use is often referred to as a “laboratory developed test,” “LDT,” or “in-house test”.

ISO 21474-2:2022由国际标准化组织 IX-ISO 发布于 2022-05-13。

ISO 21474-2:2022 发布之时，引用了标准

• ISO 15189 医学实验室.质量和能力的特殊要求*， 2023-07-02 更新
• ISO 21474-1 体外诊断医疗器械 - 多重分子测试的一般要求和术语

* 在 ISO 21474-2:2022 发布之后有更新，请注意新发布标准的变化。

ISO 21474-2:2022的历代版本如下：

• 2022年 ISO 21474-2:2022 体外诊断医疗器械.核酸的多重分子试验.第2部分:验证和验证

标准号

ISO 21474-2:2022

发布

2022年

发布单位

国际标准化组织

当前最新

ISO 21474-2:2022

 

 

引用标准

ISO 15189 ISO 21474-1

推荐